Bleeding Academic Research Consortium: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
=='Bleeding Academic Research Consortium (BARC)' definition for Bleeding (DONOT EDIT)<ref name="pmid21670242">{{cite journal| author=Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al.| title=Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. | journal=Circulation | year= 2011 | volume= 123 | issue= 23 | pages= 2736-47 | pmid=21670242 | doi=10.1161/CIRCULATIONAHA.110.009449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21670242 }} </ref> | |||
{{cquote| | |||
* | *===Type 0===: no bleeding | ||
* | *===Type 1===: bleeding that is not actionable and does not cause the patient to seek unscheduled performance of studies, hospitalization, or treatment by a health-care professional; may include episodes leading to self-discontinuation of medical therapy by the patient without consulting a health-care professional. | ||
* | *===Type 2===: any overt, actionable sign of hemorrhage (eg, more bleeding than would be expected for a clinical circumstance, including bleeding found by imaging alone) that does not fit the criteria for type 3, 4, or 5 but does meet at least one of the following criteria: (1) requiring nonsurgical, medical intervention by a health-care professional, (2) leading to hospitalization or increased level of care, or (3) prompting evaluation | ||
* | *===Type 3=== | ||
* | **====Type 3a====: Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL* (provided hemoglobin drop is related to bleed)Any transfusion with overt bleeding | ||
* | **====Type 3b====: Overt bleeding plus hemoglobin drop more than or equal to 5 g/dL* (provided hemoglobin drop is related to bleed)Cardiac tamponade, Bleeding requiring surgical intervention for control (excludingdental/nasal/skin/hemorrhoid), Bleeding requiring intravenous vasoactive agents | ||
**====Type 3c====: Intracranial hemorrhage (does not include microbleeds or hemorrhagic transformation, does include intraspinal), Subcategories confirmed by autopsy or imaging or lumbar puncture, Intraocular bleed compromising vision. | |||
**====Type 4====: CABG-related bleeding, Perioperative intracranial bleeding within 48 h, Reoperation after closure of sternotomy for the purpose of controlling bleeding | |||
Transfusion of more than equal to 5 U whole blood or packed red blood cells within a 48-h period, Chest tube output more than or equal to 2L within a 24-h period | Transfusion of more than equal to 5 U whole blood or packed red blood cells within a 48-h period, Chest tube output more than or equal to 2L within a 24-h period | ||
* | *===Type 5===: fatal bleeding | ||
* | **====Type 5a====: Probable fatal bleeding; no autopsy or imaging confirmation but clinically suspicious | ||
* | **====Type 5b====: Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation | ||
Revision as of 00:58, 17 June 2011
=='Bleeding Academic Research Consortium (BARC)' definition for Bleeding (DONOT EDIT)[1]
{{cquote|
- ===Type 0===: no bleeding
- ===Type 1===: bleeding that is not actionable and does not cause the patient to seek unscheduled performance of studies, hospitalization, or treatment by a health-care professional; may include episodes leading to self-discontinuation of medical therapy by the patient without consulting a health-care professional.
- ===Type 2===: any overt, actionable sign of hemorrhage (eg, more bleeding than would be expected for a clinical circumstance, including bleeding found by imaging alone) that does not fit the criteria for type 3, 4, or 5 but does meet at least one of the following criteria: (1) requiring nonsurgical, medical intervention by a health-care professional, (2) leading to hospitalization or increased level of care, or (3) prompting evaluation
- ===Type 3===
- ====Type 3a====: Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL* (provided hemoglobin drop is related to bleed)Any transfusion with overt bleeding
- ====Type 3b====: Overt bleeding plus hemoglobin drop more than or equal to 5 g/dL* (provided hemoglobin drop is related to bleed)Cardiac tamponade, Bleeding requiring surgical intervention for control (excludingdental/nasal/skin/hemorrhoid), Bleeding requiring intravenous vasoactive agents
- ====Type 3c====: Intracranial hemorrhage (does not include microbleeds or hemorrhagic transformation, does include intraspinal), Subcategories confirmed by autopsy or imaging or lumbar puncture, Intraocular bleed compromising vision.
- ====Type 4====: CABG-related bleeding, Perioperative intracranial bleeding within 48 h, Reoperation after closure of sternotomy for the purpose of controlling bleeding
Transfusion of more than equal to 5 U whole blood or packed red blood cells within a 48-h period, Chest tube output more than or equal to 2L within a 24-h period
- ===Type 5===: fatal bleeding
- ====Type 5a====: Probable fatal bleeding; no autopsy or imaging confirmation but clinically suspicious
- ====Type 5b====: Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation
- ↑ Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J; et al. (2011). "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium". Circulation. 123 (23): 2736–47. doi:10.1161/CIRCULATIONAHA.110.009449. PMID 21670242.